Aligos Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
25 Oct 23 | Buy€5,671,519 | Roche Holding AG | Company | 317,344.04 | €17.87 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 175,549 | 2.85% |
Public Companies | 441,038 | 7.15% |
Hedge Funds | 1,670,669 | 27.1% |
General Public | 1,868,160 | 30.3% |
Institutions | 2,009,331 | 32.6% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 30.9%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
1,670,669 | €12.0m | 0% | 0.11% | |||
441,038 | €3.2m | 0% | no data | |||
290,256 | €2.1m | 5.27% | 0.06% | |||
255,578 | €1.8m | 0% | 0.06% | |||
244,110 | €1.8m | 0% | 0.05% | |||
200,000 | €1.4m | 103% | no data | |||
141,881 | €1.0m | 0% | 0.09% | |||
125,451 | €903.3k | 10,400% | no data | |||
124,867 | €899.1k | 63.8% | 0.01% | |||
85,972 | €619.1k | 0% | no data | |||
76,248 | €549.0k | 0% | 0.01% | |||
66,000 | €475.2k | 0% | 0.05% | |||
63,814 | €459.5k | 57.5% | no data | |||
60,414 | €435.0k | 0% | no data | |||
58,317 | €419.9k | -37.2% | 0.18% | |||
50,400 | €362.9k | -22.7% | 0.07% | |||
40,000 | €288.0k | 100% | 0.02% | |||
33,179 | €238.9k | 26.1% | no data | |||
32,641 | €235.0k | -28.9% | no data | |||
30,753 | €221.4k | -4.88% | no data | |||
29,728 | €214.1k | 0% | 0.09% | |||
28,771 | €207.2k | -40.1% | 0.03% | |||
26,220 | €188.8k | 0% | 0.05% | |||
21,248 | €153.0k | 0% | no data | |||
16,227 | €116.8k | 8.75% | no data |